Breakthrough selectively represses immune system: New hope for multiple sclerosis, type 1 diabetes, food allergies, and asthma
Sunday, November 18, 2012 - 15:32
in Health & Medicine
Innovative biotechnology selectively inhibits the part of the immune system responsible for attacking myelin and gives new hope to those suffering from autoimmune diseases such as multiple sclerosis, type 1 diabetes, food allergies, and asthma.